Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method

被引:26
作者
Armson, A [1 ]
Meloni, BP [1 ]
Reynoldson, JA [1 ]
Thompson, RCA [1 ]
机构
[1] Murdoch Univ, Div Vet & Biomed Sci, WHO, Collaborating Ctr Mol Epidemiol Parasit Infect, Perth, WA, Australia
关键词
Cryptosporidium parvum; inhibition; in vitro test; coccidiostat; cryptosporidiosis; drug;
D O I
10.1111/j.1574-6968.1999.tb08681.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A rapid semi-quantitative screening method was devised for assessing the anticryptosporidial and cytotoxic effects of putative chemotherapeutic compounds. The method is suitable as an initial rapid screening procedure from which compounds demonstrating anticryptosporidial activity can be identified for further analysis. It has the advantages of speed, low cost and concurrent assessment of anticryptosporidial and cytotoxic effects and allows accurate determination of minimum lethal concentrations. Of the 71 compounds screened, six completely inhibited cryptosporidial growth at 1 mu M (monensin, salinomycin, alborixin, lasalocid, trifluralin and nicarbazin) and a further eight showed significant anticryptosporidial activity at 1 or 20 mu M (halquinol, bleomycin, suramin, mitomycin, doxycycline hydrochloride, toltrazuril, chloroquine phosphate and teniposide). Twelve compounds were found to have some degree cytotoxicity at 1 mu M and a further 12 at 20 mu M. (C) 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 18 条
  • [1] INHIBITION OF CRYPTOSPORIDIUM-PARVUM IN NEONATAL HSD-(ICR)BR SWISS MICE BY POLYETHER IONOPHORES AND AROMATIC AMIDINES
    BLAGBURN, BL
    SUNDERMANN, CA
    LINDSAY, DS
    HALL, JE
    TIDWELL, RR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) : 1520 - 1523
  • [2] BRASSEUR P, 1991, J PROTOZOOL, V38, pS230
  • [3] CAMA VA, 1994, J EUKARYOT MICROBIOL, V41, pS25
  • [4] EPIDEMIOLOGIC ASPECTS OF HUMAN CRYPTOSPORIDIOSIS
    CASEMORE, DP
    [J]. EPIDEMIOLOGY AND INFECTION, 1990, 104 (01) : 1 - 28
  • [5] Current W. L., 1989, Parasitic infections in the compromised host., P281
  • [6] Fayer R., 1990, P1
  • [7] GUTTERIDGE WE, 1991, J PROTOZOOL, V38, pS141
  • [8] SUMMARY OF THE WORKSHOP ON FUTURE-DIRECTIONS IN DISCOVERY AND DEVELOPMENT OF THERAPEUTIC AGENTS FOR OPPORTUNISTIC INFECTIONS ASSOCIATED WITH AIDS
    LAUGHON, BE
    ALLAUDEEN, HS
    BECKER, JM
    CURRENT, WL
    FEINBERG, J
    FRENKEL, JK
    HAFNER, R
    HUGHES, WT
    LAUGHLIN, CA
    MEYERS, JD
    SCHRAGER, LK
    YOUNG, LS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (02) : 244 - 251
  • [9] PUTATIVE ANTICRYPTOSPORIDIAL AGENTS TESTED WITH AN IMMUNODEFICIENT MOUSE MODEL
    LEITCH, GJ
    HE, Q
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) : 865 - 867
  • [10] ASSESSMENT OF CANDIDATE ANTICRYPTOSPORIDIAL AGENTS IN AN IMMUNOSUPPRESSED RAT MODEL
    LEMETEIL, D
    ROUSSEL, F
    FAVENNEC, L
    BALLET, JJ
    BRASSEUR, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) : 766 - 768